NSEI:BAYERCROP

Stock Analysis Report

Executive Summary

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products in India.

Snowflake

Fundamentals

Flawless balance sheet with reasonable growth potential and pays a dividend.


Similar Companies

Share Price & News

How has Bayer CropScience's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BAYERCROP has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-7.6%

BAYERCROP

-2.4%

IN Chemicals

-1.2%

IN Market


1 Year Return

-15.7%

BAYERCROP

8.9%

IN Chemicals

4.0%

IN Market

Return vs Industry: BAYERCROP underperformed the Indian Chemicals industry which returned 8.9% over the past year.

Return vs Market: BAYERCROP underperformed the Indian Market which returned 4% over the past year.


Shareholder returns

BAYERCROPIndustryMarket
7 Day-7.6%-2.4%-1.2%
30 Day0.2%0.9%4.8%
90 Day6.6%9.7%7.5%
1 Year-15.2%-15.7%11.6%8.9%6.1%4.0%
3 Year-15.1%-16.2%57.9%51.5%34.2%27.3%
5 Year16.4%13.9%119.4%102.7%37.4%24.5%

Price Volatility Vs. Market

How volatile is Bayer CropScience's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Bayer CropScience undervalued compared to its fair value and its price relative to the market?

57.32x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: BAYERCROP (₹3340.9) is trading above our estimate of fair value (₹1395.21)

Significantly Below Fair Value: BAYERCROP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: BAYERCROP is poor value based on its PE Ratio (57.3x) compared to the Chemicals industry average (11.1x).

PE vs Market: BAYERCROP is poor value based on its PE Ratio (57.3x) compared to the Indian market (13.2x).


Price to Earnings Growth Ratio

PEG Ratio: BAYERCROP is poor value based on its PEG Ratio (1.8x)


Price to Book Ratio

PB vs Industry: BAYERCROP is overvalued based on its PB Ratio (6.2x) compared to the IN Chemicals industry average (1.1x).


Next Steps

Future Growth

How is Bayer CropScience forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

31.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BAYERCROP's forecast earnings growth (31.1% per year) is above the savings rate (7.6%).

Earnings vs Market: BAYERCROP's earnings (31.1% per year) are forecast to grow faster than the Indian market (19% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: BAYERCROP's revenue (11.6% per year) is forecast to grow faster than the Indian market (11.2% per year).

High Growth Revenue: BAYERCROP's revenue (11.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: BAYERCROP's Return on Equity is forecast to be low in 3 years time (14.2%).


Next Steps

Past Performance

How has Bayer CropScience performed over the past 5 years?

-10.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BAYERCROP has large one-off items impacting its financial results.

Growing Profit Margin: BAYERCROP's current net profit margins (7.4%) are lower than last year (10.6%).


Past Earnings Growth Analysis

Earnings Trend: BAYERCROP's earnings have declined by -10.3% per year over the past 5 years.

Accelerating Growth: BAYERCROP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: BAYERCROP had negative earnings growth (-26.5%) over the past year, making it difficult to compare to the Chemicals industry average (14.4%).


Return on Equity

High ROE: BAYERCROP's Return on Equity (8.8%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Bayer CropScience's financial position?


Financial Position Analysis

Short Term Liabilities: BAYERCROP's short term assets (₹29.7B) exceeds its short term liabilities (₹12.4B)

Long Term Liabilities: BAYERCROP's short term assets (29.7B) exceeds its long term liabilities (1.2B)


Debt to Equity History and Analysis

Debt Level: BAYERCROP is debt free.

Reducing Debt: BAYERCROP had no debt 5 years ago.

Debt Coverage: BAYERCROP has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: BAYERCROP has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: BAYERCROP has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if BAYERCROP's debt is covered by short term assets.


Next Steps

Dividend

What is Bayer CropScience's current dividend yield, its reliability and sustainability?

0.54%

Current Dividend Yield


Dividend Yield vs Market

company0.5%marketbottom25%0.6%markettop25%2.4%industryaverage0.9%forecastin3Years0.6%

Current dividend yield vs market & industry

Notable Dividend: BAYERCROP's dividend (0.54%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.57%).

High Dividend: BAYERCROP's dividend (0.54%) is low compared to the top 25% of dividend payers in the Indian market (2.4%).


Stability and Growth of Payments

Stable Dividend: BAYERCROP's dividends per share have been stable in the past 10 years.

Growing Dividend: BAYERCROP's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (30.9%), BAYERCROP's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: BAYERCROP's dividends in 3 years are forecast to be well covered by earnings (21.4% payout ratio).


Next Steps

Management

What is the CEO of Bayer CropScience's salary, the management and board of directors tenure and is there insider trading?

4.4yrs

Average management tenure


CEO

Duraiswami Narain (56yo)

0.9yrs

Tenure

₹106,930,000

Compensation

Mr. Duraiswami Narain has been Vice Chairman & Managing Director and CEO of Bayer CropScience Limited since December 1, 2018 and its Director since October 23, 2018. Mr. Narain served as Vice President and ...


CEO Compensation Analysis

Compensation vs Market: Duraiswami's total compensation ($USD1.49M) is above average for companies of similar size in the Indian market ($USD615.49K).

Compensation vs Earnings: Insufficient data to compare Duraiswami's compensation with company performance.


Management Age and Tenure

4.4yrs

Average Tenure

57yo

Average Age

Experienced Management: BAYERCROP's management team is considered experienced (4.4 years average tenure).


Board Age and Tenure

0.8yrs

Average Tenure

55yo

Average Age

Experienced Board: BAYERCROP's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.7%.


Management Team

  • Rajiv Wani (60yo)

    Head of Law

    • Tenure: 7yrs
    • Compensation: ₹16.48m
  • Pravin Trama (49yo)

    General Manager of Zonal Accounts

    • Tenure: 0yrs
    • Compensation: ₹2.63m
  • Asif Tanweer (63yo)

    General Manager of Business Development & Stewardship

    • Tenure: 35.1yrs
    • Compensation: ₹2.70m
  • Ajit Sawant (73yo)

    Head of Manufacturing

    • Tenure: 0yrs
    • Compensation: ₹2.71m
  • Bernd Lohmann (51yo)

    Head of BBS AP ODC

    • Tenure: 0yrs
    • Compensation: ₹23.42m
  • Anil Jain (63yo)

    VP of Marketing & Co-operations

    • Tenure: 0yrs
    • Compensation: ₹4.43m
  • Joerg Rehbein

    Head of Bayer CropScience

    • Tenure: 0yrs
  • Mathias Kremer (57yo)

    Head of Strategy & Portfolio Management

    • Tenure: 4.4yrs
  • Duraiswami Narain (56yo)

    Vice Chairman

    • Tenure: 0.9yrs
    • Compensation: ₹106.93m
  • Rolf Hoffmann (43yo)

    CFO & Director

    • Tenure: 0.4yrs

Board Members

  • Sekhar Natarajan (66yo)

    Additional Non-Executive & Independent Director

    • Tenure: 0.08yrs
  • Jens Hartmann (53yo)

    Non-Executive & Non-Independent Director

    • Tenure: 0.8yrs
    • Compensation: ₹18.91m
  • Thomas Hoffmann (48yo)

    Additional Non-Executive Director

    • Tenure: 6.6yrs
    • Compensation: ₹39.14m
  • Duraiswami Narain (56yo)

    Vice Chairman

    • Tenure: 0.9yrs
    • Compensation: ₹106.93m
  • Ketaki Bhagwati (55yo)

    Independent Woman Director

    • Tenure: 0.8yrs
    • Compensation: ₹60.00k
  • Pankaj Patel (66yo)

    Independent Chairman of the Board

    • Tenure: 3.3yrs
    • Compensation: ₹1.61m
  • Rolf Hoffmann (43yo)

    CFO & Director

    • Tenure: 0.4yrs

Company Information

Bayer CropScience Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Bayer CropScience Limited
  • Ticker: BAYERCROP
  • Exchange: NSEI
  • Founded: 1958
  • Industry: Fertilizers and Agricultural Chemicals
  • Sector: Materials
  • Market Cap: ₹116.619b
  • Shares outstanding: 34.33m
  • Website: https://www.bayer.in

Number of Employees


Location

  • Bayer CropScience Limited
  • Bayer House
  • Central Avenue
  • Thane
  • Maharashtra
  • 400076
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
506285BSE (Mumbai Stock Exchange)YesEquity SharesININRJul 2001
BAYERCROPNSEI (National Stock Exchange of India)YesEquity SharesININRJul 2001

Biography

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products in India. It also provides pharmaceutical produ ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/13 12:56
End of Day Share Price2019/11/13 00:00
Earnings2019/09/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.